151 related articles for article (PubMed ID: 8070302)
1. Simvastatin in non-insulin-dependent diabetes mellitus: effect on serum lipids, lipoproteins and haemostatic measures.
Farrer M; Winocour PH; Evans K; Neil HA; Laker MF; Kesteven P; Alberti KG
Diabetes Res Clin Pract; 1994 Mar; 23(2):111-9. PubMed ID: 8070302
[TBL] [Abstract][Full Text] [Related]
2. Effects of simvastatin versus gemfibrozil on lipids and glucose control in patients with non-insulin-dependent diabetes mellitus. NIDDM Study Group.
Sweany AE; Shapiro DR; Tate AC; Goldberg RB; Stein EA
Clin Ther; 1995; 17(2):186-203. PubMed ID: 7614520
[TBL] [Abstract][Full Text] [Related]
3. Randomized placebo-controlled study of the effects of simvastatin on haemostatic variables, lipoproteins and free fatty acids. The Oxford Cholesterol Study Group.
Mitropoulos KA; Armitage JM; Collins R; Meade TW; Reeves BE; Wallendszus KR; Wilson SS; Lawson A; Peto R
Eur Heart J; 1997 Feb; 18(2):235-41. PubMed ID: 9043839
[TBL] [Abstract][Full Text] [Related]
4. Comparison of bezafibrate and simvastatin in the treatment of dyslipidaemia in patients with NIDDM.
Jeck T; Riesen WF; Keller U
Diabet Med; 1997 Jul; 14(7):564-70. PubMed ID: 9223394
[TBL] [Abstract][Full Text] [Related]
5. Hypercholesterolemia in non-insulin-dependent diabetes mellitus: different effect of simvastatin on VLDL and LDL cholesterol levels.
Cassader M; Ruiu G; Gambino R; Alemanno N; Veglia F; Pagano G
Atherosclerosis; 1993 Feb; 99(1):47-53. PubMed ID: 8461059
[TBL] [Abstract][Full Text] [Related]
6. Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia.
Saku K; Sasaki J; Arakawa K
Clin Ther; 1989; 11(2):247-57. PubMed ID: 2736571
[TBL] [Abstract][Full Text] [Related]
7. Simvastatin compared to fluvastatin in the reduction of serum lipids and apolipoproteins in patients with ischaemic heart disease and moderate hypercholesterolaemia.
Sigurdsson G; Haraldsdottir SO; Melberg TH; Tikkanen MJ; Miettinen TE; Kristianson KJ
Acta Cardiol; 1998; 53(1):7-14. PubMed ID: 9638964
[TBL] [Abstract][Full Text] [Related]
8. Successful management of primary hypercholesterolaemia with simvastatin and low-dose colestipol.
Simons LA; Simons J; Parfitt A
Med J Aust; 1992 Oct; 157(7):455-9. PubMed ID: 1406395
[TBL] [Abstract][Full Text] [Related]
9. The influence of simvastatin alone or in combination with gemfibrozil on plasma lipids and lipoproteins in patients with type III hyperlipoproteinemia.
Feussner G; Eichinger M; Ziegler R
Clin Investig; 1992 Nov; 70(11):1027-35. PubMed ID: 1472833
[TBL] [Abstract][Full Text] [Related]
10. Long-term effects of a sustained-release preparation of acipimox on dyslipidemia and glucose metabolism in non-insulin-dependent diabetes mellitus.
Davoren PM; Kelly W; Gries FA; Hubinger A; Whately-Smith C; Alberti KG
Metabolism; 1998 Mar; 47(3):250-6. PubMed ID: 9500558
[TBL] [Abstract][Full Text] [Related]
11. Renal function and insulin sensitivity during simvastatin treatment in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria.
Nielsen S; Schmitz O; Møller N; Pørksen N; Klausen IC; Alberti KG; Mogensen CE
Diabetologia; 1993 Oct; 36(10):1079-86. PubMed ID: 8243858
[TBL] [Abstract][Full Text] [Related]
12. Plasma lipoproteins and renal function during simvastatin treatment in diabetic nephropathy.
Hommel E; Andersen P; Gall MA; Nielsen F; Jensen B; Rossing P; Dyerberg J; Parving HH
Diabetologia; 1992 May; 35(5):447-51. PubMed ID: 1521727
[TBL] [Abstract][Full Text] [Related]
13. Effects of simvastatin and fenofibrate on serum lipoproteins and apolipoproteins in primary hypercholesterolaemia.
Stohler R; Keller U; Riesen WF
Eur J Clin Pharmacol; 1989; 37(2):199-203. PubMed ID: 2507323
[TBL] [Abstract][Full Text] [Related]
14. Simvastatin treatment of hypercholesterolemia in patients with insulin dependent diabetes mellitus.
Sartor G; Katzman P; Eizyk E; Kalén J; Nilsson A; Ugander L; Ursing D
Int J Clin Pharmacol Ther; 1995 Jan; 33(1):3-6. PubMed ID: 7711988
[TBL] [Abstract][Full Text] [Related]
15. Comparative effects of simvastatin and cholestyramine in treatment of patients with hypercholesterolaemia.
Mölgaard J; von Schenck H; Olsson AG
Eur J Clin Pharmacol; 1989; 36(5):455-60. PubMed ID: 2502417
[TBL] [Abstract][Full Text] [Related]
16. Effects of simvastatin on fasting and postprandial triglyceride-rich lipoproteins in patients with type I diabetes mellitus.
Noutsou M; Georgopoulos A
J Diabetes Complications; 1999; 13(2):98-104. PubMed ID: 10432174
[TBL] [Abstract][Full Text] [Related]
17. Effects of diet and simvastatin on serum lipids, insulin, and antioxidants in hypercholesterolemic men: a randomized controlled trial.
Jula A; Marniemi J; Huupponen R; Virtanen A; Rastas M; Rönnemaa T
JAMA; 2002 Feb; 287(5):598-605. PubMed ID: 11829698
[TBL] [Abstract][Full Text] [Related]
18. The effects of lipid lowering drugs on metabolic control and lipoprotein composition in type 2 diabetic patients with mild hyperlipidaemia.
Stewart MW; Dyer RG; Alberti KG; Laker MF
Diabet Med; 1995 Mar; 12(3):250-7. PubMed ID: 7758262
[TBL] [Abstract][Full Text] [Related]
19. Simvastatin, transdermal patch, and oral estrogen-progestogen preparation in early-postmenopausal hypercholesterolemic women: a randomized, placebo-controlled clinical trial.
Vigna GB; Donegà P; Zanca R; Barban A; Passaro A; Pansini F; Bonaccorsi G; Mollica G; Fellin R
Metabolism; 2002 Nov; 51(11):1463-70. PubMed ID: 12404199
[TBL] [Abstract][Full Text] [Related]
20. Comparison between simvastatin and bezafibrate in effect on plasma lipoproteins and apolipoproteins in primary hypercholesterolaemia.
Schulzeck P; Bojanovski M; Jochim A; Canzler H; Bojanovski D
Lancet; 1988 Mar; 1(8586):611-3. PubMed ID: 2894548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
